As a leader in precision radiation therapy solutions and personalized radiotherapy treatments, Elekta is committed to ensuring that every patient has access to the best cancer care possible.

ERECTILE Function Preservation for Prostate Cancer Radiation Therapy

In this video, Dr. Jochem van der Voort van Zyp, MD, PhD, a radiation oncologist at UMC Utrecht, The Netherlands, explains the ERECT trial, a phase two study that aims to reduce the risk of erectile dysfunction for prostate cancer patients undergoing radiation therapy.

The ERECT trial uses MR-guided radiation therapy that allows for better visibility and contrast of the prostate and the surrounding structures that are important for erectile function, such as the neurovascular bundles and the internal pudendal artery. By de-escalating the dose to these structures, the ERECT trial hopes to preserve the erectile function of patients while still delivering an effective dose to the tumor.

Dr. Jochem van der Voort van Zyp also discusses the treatment scheme, the benefits, and the challenges of the ERECT trial, and shares his hopes for the future of MR-guided radiation therapy for prostate cancer patients.

If you are interested in learning more about the ERECT trial and how MR-guided radiation therapy can help improve the outcomes and the quality of life of prostate cancer patients, visit Elekta website here:

Receiving radiation treatment?
Additional Information for patients can be found on our website:

Related Videos